Unveiling IL-33/ST2 Pathway Unbalance in Cardiac Remodeling Due to Obesity in Zucker Fatty Rats
Authors:
- Clementina SitziaClementina Sitzia
- Elena VianelloElena Vianello
- Elena DozioEDElena Dozio
- Marta KalousováMKMarta Kalousová
- Tomáš ZimaTZTomáš Zima
- Stefano BrizzolaSBStefano Brizzola
- Paola RoccabiancaPaola Roccabianca
- Gabriella TedeschiGTGabriella Tedeschi
- John LamontJLJohn Lamont
- Lorenza TacchiniLTLorenza Tacchini
- Massimiliano Marco Corsi-RomanelliMassimiliano Marco Corsi-Romanelli
Open Access
- 19 January 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 1991
Abstract
Obesity is an epidemic condition linked to cardiovascular disease severity and mortality. Fat localization and type represent cardiovascular risk estimators. Importantly, visceral fat secretes adipokines known to promote low-grade inflammation that, in turn, modulate its secretome and cardiac metabolism. In this regard, IL-33 regulates the functions of various immune cells through ST2 binding and—following its role as an immune sensor to infection and stress—is involved in the pro-fibrotic remodeling of the myocardium. Here we further investigated the IL-33/ST2 effects on cardiac remodeling in obesity, focusing on molecular pathways linking adipose-derived IL-33 to the development of fibrosis or hypertrophy. We analyzed the Zucker Fatty rat model, and we developed in vitro models to mimic the adipose and myocardial relationship. We demonstrated a dysregulation of IL-33/ST2 signaling in both adipose and cardiac tissue, where they affected Epac proteins and myocardial gene expression, linked to pro-fibrotic signatures. In Zucker rats, pro-fibrotic effects were counteracted by ghrelin-induced IL-33 secretion, whose release influenced transcription factor expression and ST2 isoforms balance regulation. Finally, the effect of IL-33 signaling is dependent on several factors, such as cell types’ origin and the balancing of ST2 isoforms. Noteworthy, it is reasonable to state that considering IL-33 to have a unique protective role should be considered over-simplistic.Keywords
Funding Information
- Italian Ministry of Health, Ricerca Corrente (Exceles LX22NPO5104, MH CZ DRO VFN 64165)
- Ministry of Education, Youth and Sport of the Czech Republic (Exceles LX22NPO5104, MH CZ DRO VFN 64165)
- Czech Ministry of Health (Exceles LX22NPO5104, MH CZ DRO VFN 64165)
- Cooperatio Medical Diagnostics (Exceles LX22NPO5104, MH CZ DRO VFN 64165)
This publication has 51 references indexed in Scilit:
- Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic FibrosisImmunity, 2013
- Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculatureJournal of Molecular and Cellular Cardiology, 2013
- IL-33 Attenuates Anoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis by Inhibition of PKCβ/JNK PathwayPLOS ONE, 2013
- Soluble ST2 Associates with Diabetes but Not Established Cardiovascular Risk Factors: A New Inflammatory Pathway of Relevance to Diabetes?PLOS ONE, 2012
- IL-33 Independently Induces Eosinophilic Pericarditis and Cardiac DilationCirculation: Heart Failure, 2012
- Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 SignalingCirculation: Heart Failure, 2009
- Cardioprotective effect of adiponectin is partially mediated by its AMPK-independent antinitrative actionAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Leptin: obesity, diabetes and other peripheral effects - a reviewPediatric Diabetes, 2003
- Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key?Gene, 1999
- Molecular Cloning of Rat Leptin Receptor Isoform Complementary DNAs—Identification of a Missense Mutation in Zucker Fatty (fa/fa) RatsBiochemical and Biophysical Research Communications, 1996